# An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

> **NCT03713424** · PHASE2 · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 30 (estimated)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** Clavulanic Acid
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03713424
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-26
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03713424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03713424, "An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT03713424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*